D. Boral Capital initiated coverage of Cero Therapeutics (CERO) with a Buy rating and $11 price target The company’s proprietary platform, designed to endow T cells with both innate and adaptive ...

Crux Capital has spun off one of its portfolio companies ... initial investment,” Crux Managing Partner Wayne Moore told D CEO. “We had nearly tripled revenue and EBITDA during our 5-year ...

Net income in Q1 rose by 7.7% year over year, reaching $1.4 billion. Capital One Financial is a leading U.S. financial corporation, renowned for its credit card, consumer, and commercial banking ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Capital punishment is vengeance rather than retribution and, as such, is a morally dubious concept The anticipatory suffering of the criminal, who may be kept on death row for many years ...

With U.S. stock markets set to open in two hours, Comfort Systems USA Inc. (FIX) was up 9.8% in pre-market trading, and GE HealthCare Technologies Inc. (GEHC) was up 4.9%. Back To Top ...

The Capital City Activity Center/Meals on Wheels Greater Frankfort will resume regular programming for members and guests beginning Monday. Since the historic flooding on April 5, the center has ...

While policy inertia and geopolitical instability are cited as major challenges, EY’s head of R&D, Government and Investment Incentives, Malia Forner, told Capital Brief the issue goes beyond politics ...